HALEIGH POE: Open Payments
NPI 1023724655 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 60 payments from 15 companies in 2025. Trend: 2023 $89 · 2024 $373 · 2025 $909
Food & beverage: $814Education: $95
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $193 |
| Otsuka America Pharmaceutical, Inc. | 5 | $85 |
| ABBVIE INC. | 4 | $60 |
| Corium, LLC | 3 | $57 |
| PFIZER INC. | 3 | $57 |
| Novo Nordisk Inc | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $21 |
| Organogenesis Inc. | 1 | $19 |
Products named: FANAPT, CAPLYTA, REXULTI, Azstarys, VRAYLAR, NURTEC ODT, Auvelity, ELIQUIS.
Industry payments across IN — which companies pay providers there.
